186 studies found for:    Panitumumab
Show Display Options
Rank Status Study
1 Recruiting Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: Panitumumab;   Drug: Cabozantinib
2 Completed Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
Conditions: Colon Cancer;   Colorectal Cancer;   Gastrointestinal Cancer;   Metastatic Colorectal Cancer;   Rectal Cancer
Interventions: Drug: Panitumumab;   Drug: Ganitumab;   Drug: Rilotumumab;   Drug: Placebo
3 Terminated
Has Results
Panitumumab and Irinotecan for Malignant Gliomas
Condition: Malignant Glioma of Brain
Interventions: Drug: Irinotecan;   Drug: Panitumumab
4 Active, not recruiting Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Panitumumab
5 Completed
Has Results
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin Based Chemotherapy;   Drug: Panitumumab;   Drug: Irinotecan Based Chemotherapy;   Drug: Bevacizumab
6 Completed
Has Results
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Panitumumab;   Drug: Carboplatin;   Drug: Gemcitabine
7 Completed Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer
Conditions: Rectal Cancer;   Colon Cancer
Interventions: Drug: FOLFOX-4;   Drug: AMG 706;   Biological: Panitumumab (Part 1a only);   Drug: FOLFIRI
8 Terminated
Has Results
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer
Conditions: Lung Cancer;   Pancreatic Cancer;   Esophageal Cancer
Interventions: Drug: AMG 706;   Biological: Panitumumab;   Drug: Gemcitabine;   Drug: Cisplatin
9 Recruiting Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Maintenance Chemotherapy;   Drug: Panitumumab (Within maintenance phase);   Drug: mFOLFOX6 (Within re-induction phase);   Drug: Panitumumab (Within re-induction phase)
10 Active, not recruiting Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Radiation: Radiation Therapy
11 Recruiting Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type KRAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: panitumumab;   Drug: Randomization to No Panitumumab
12 Unknown  PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
Condition: Cholangiocarcinomas
Interventions: Drug: Cisplatin, Gemcitabine, Panitumumab;   Drug: Cisplatin, Gemcitabine
13 Active, not recruiting Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: Carboplatin;   Drug: Pemetrexed;   Drug: Panitumumab
14 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
Conditions: Colorectal Cancer;   Metastatic Cancer
Intervention: Biological: Panitumumab
15 Completed
Has Results
Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Irinotecan;   Biological: Panitumumab;   Drug: 5-Fluorouracil;   Drug: Leucovorin
16 Terminated
Has Results
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Panitumumab;   Procedure: Surgery;   Procedure: Radiation Therapy
17 Recruiting Panitumumab Pediatric Study
Condition: Solid Tumors
Intervention: Drug: Panitumumab Treatment
18 Active, not recruiting
Has Results
PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer
Interventions: Drug: Panitumumab;   Drug: Bevacizumab;   Drug: mFOLFOX6
19 Completed Chemoradiation and Panitumumab for Esophageal Cancer
Conditions: Squamous Cell Carcinoma;   Adenocarcinoma;   Esophageal Cancer;   Gastro-esophageal Junction Cancer
Interventions: Drug: Carboplatin;   Drug: Paclitaxel;   Drug: panitumumab;   Radiation: radiotherapy
20 Not yet recruiting Panitumumab and RAS, DIagnostically-useful Gene Mutation for mCRC
Condition: Colorectal Cancer
Interventions: Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab;   Drug: oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years